Galena Biopharma (GALE) +21.9% premarket after receiving a Notice of Allowance from the U.S....

|About: Galena Biopharma, Inc. (GALE)|By:, SA News Editor

Galena Biopharma (GALE) +21.9% premarket after receiving a Notice of Allowance from the U.S. patent office for a patent covering the use of its NeuVax product candidate, a vaccine for inducing immunity to breast cancer recurrence in some patients. (PR)